StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)

Close on Nov 17, 2026Market cap $792.42MP/E –Yield –

Ardelyx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Ardelyx's market cap was $779.83M on Nov 11, 2026, against $1.41B a year earlier. Over the last 5 years it ranged from $80.42M to $2.17B, with a median of $1.05B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$779.83M-44.9%
2025Dec 31, 2025$1.42B+17.9%
2024Dec 31, 2024$1.20B-16.5%
2023Dec 29, 2023$1.44B+169.5%
2022Dec 30, 2022$534.09M+354.7%
2021Dec 31, 2021$117.45M-79.9%
2020Dec 31, 2020$583.87M+23.7%
2019Dec 31, 2019$471.94M+324.5%
2018Dec 31, 2018$111.17M-64.5%
2017Dec 29, 2017$313.53M-53.3%
2016Dec 30, 2016$671.60M+42.8%
2015Dec 31, 2015$470.30M+35.3%
2014Dec 31, 2014$347.57M–

More Ardelyx figures

See a number that looks wrong?